Illumina Inc., a leading genomic sequencing company, has agreed to pay $9.8 million to settle federal allegations that it knowingly sold cybersecurity-vulnerable genomic sequencing systems to government agencies while misrepresenting their security standards. The settlement resolves claims spanning over seven years of alleged violations that put sensitive genetic information at risk across multiple federal departments. […]The post Illumina Fined $9.8M for Cybersecurity Flaws in Genomic Tools Sold to U.S. Agencies appeared first on GBHackers Security | #1 Globally Trusted Cyber Security News Platform.